Cargando…

Randomized Controlled Trials of Add-On Antidepressants in Schizophrenia

BACKGROUND: Despite adequate treatment with antipsychotics, a substantial number of patients with schizophrenia demonstrate only suboptimal clinical outcome. To overcome this challenge, various psychopharmacological combination strategies have been used, including antidepressants added to antipsycho...

Descripción completa

Detalles Bibliográficos
Autores principales:	Terevnikov, Viacheslav, Joffe, Grigori, Stenberg, Jan-Henry
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4576515/ https://www.ncbi.nlm.nih.gov/pubmed/25991654 http://dx.doi.org/10.1093/ijnp/pyv049

Ejemplares similares

Scheduled Telephone Support for Internet Cognitive Behavioral Therapy for Depression in Patients at Risk for Dropout: Pragmatic Randomized Controlled Trial
por: Pihlaja, Satu, et al.
Publicado: (2020)

Celecoxib Adjunctive Treatment to Antipsychotics in Schizophrenia: A Review of Randomized Clinical Add-On Trials
por: Marini, Stefano, et al.
Publicado: (2016)

Therapeutic alliance in guided internet therapy programs for depression and anxiety disorders – A systematic review
por: Pihlaja, Satu, et al.
Publicado: (2017)

Acetyl-L-Carnitine as An Add-On Therapy for Negative and Cognitive Symptoms of Schizophrenia: A Randomized Control Trial
por: kulkarni, shalmali, et al.
Publicado: (2022)

Measurement Invariant but Non-Normal Treatment Responses in Guided Internet Psychotherapies for Depressive and Generalized Anxiety Disorders
por: Rosenström, Tom H., et al.
Publicado: (2021)

A Systematic Review on Add-On Psychotherapy in Schizophrenia Spectrum Disorders
por: Modesti, Martina Nicole, et al.
Publicado: (2023)

Antidepressive Effect of Antipsychotics in the Treatment of Schizophrenia: Meta-Regression Analysis of Randomized Placebo-Controlled Trials
por: Miura, Itaru, et al.
Publicado: (2020)

Double-blind, randomized, clinical trial of metformin as add-on treatment with clozapine in treatment of schizophrenia disorder
por: Hebrani, Paria, et al.
Publicado: (2015)

The effect of add-on memantine on global function and quality of life in schizophrenia: A randomized, double-blind, controlled, clinical trial
por: Omranifard, Victoria, et al.
Publicado: (2015)

PM405. Sodium Benzoate Add-on Treatment for Refractory Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Trial
por: Lin, Chieh-Hsin, et al.
Publicado: (2016)

Add-on effect of Brahmi in the management of schizophrenia
por: Sarkar, Sukanto, et al.
Publicado: (2012)

Augmentation with antidepressants in schizophrenia treatment: benefit or risk
por: Mao, Ye-Meng, et al.
Publicado: (2015)

The Risk of Hip Fracture Due to Mirtazapine Exposure When Switching Antidepressants or Using Other Antidepressants as Add-On Therapy
por: Leach, Michael J., et al.
Publicado: (2017)

Therapeutic efficacy of add-on yogasana intervention in stabilized outpatient schizophrenia: Randomized controlled comparison with exercise and waitlist
por: Varambally, Shivarama, et al.
Publicado: (2012)

Internet-Delivered Cognitive Behavioral Therapy for Generalized Anxiety Disorder in Nationwide Routine Care: Effectiveness Study
por: Ritola, Ville, et al.
Publicado: (2022)

Efficacy and Safety of Add-On Plant-Based Drugs for COVID-19 Patients: A Review of the Randomized Control Trials
por: Diantini, Ajeng, et al.
Publicado: (2023)

Efficacy of Zinc Sulfate as an Add-on Therapy to Risperidone Versus Risperidone Alone in Patients With Schizophrenia: A Double-Blind Randomized Placebo-Controlled Trial
por: Mortazavi, Mehran, et al.
Publicado: (2015)

Effect of add-on alpha lipoic acid on psychopathology in patients with treatment-resistant schizophrenia: a pilot randomized double-blind placebo-controlled trial
por: Mishra, Archana, et al.
Publicado: (2022)

The Potential of Scopolamine as an Antidepressant in Major Depressive Disorder: A Systematic Review of Randomized Controlled Trials
por: Moćko, Paweł, et al.
Publicado: (2023)

Barriers to yoga therapy as an add-on treatment for schizophrenia in India
por: Baspure, Shubhangi, et al.
Publicado: (2012)

S47. ADD-ON SPIRONOLACTONE FOR THE TREATMENT OF SCHIZOPHRENIA (SPIRO TREAT)
por: Roeh, Astrid, et al.
Publicado: (2018)

Effects of Add-on Ramelteon on Cognitive Impairment in Patients with Schizophrenia: An Open-label Pilot Trial
por: Shirayama, Yukihiko, et al.
Publicado: (2014)

N-acetylcysteine as add-on to antidepressant medication in therapy refractory major depressive disorder patients with increased inflammatory activity: study protocol of a double-blind randomized placebo-controlled trial
por: Yang, Chenghao, et al.
Publicado: (2018)

Adjunctive antidepressive pharmacotherapy in schizophrenia patients
por: Zink, M.
Publicado: (2021)

Acupuncture as Add-On Treatment of the Positive, Negative, and Cognitive Symptoms of Patients with Schizophrenia: A Systematic Review
por: van den Noort, Maurits, et al.
Publicado: (2018)

Add-On Effect of Chinese Herbal Medicine on Mortality in Myocardial Infarction: Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Chung, Vincent C. H., et al.
Publicado: (2013)

Add-on spironolactone as antagonist of the NRG1-ERBB4 signaling pathway for the treatment of schizophrenia: Study design and methodology of a multicenter randomized, placebo-controlled trial
por: Hasan, Alkomiet, et al.
Publicado: (2020)

Text Topics and Treatment Response in Internet-Delivered Cognitive Behavioral Therapy for Generalized Anxiety Disorder: Text Mining Study
por: Mylläri, Sanna, et al.
Publicado: (2022)

The Overall Anxiety Severity and Impairment Scale as an Outcome Measure in Internet-Delivered Cognitive Behavioral Therapy for Anxiety Disorders: Observational Study
por: Karpov, Boris, et al.
Publicado: (2023)

Adenosine modulators and calcium channel blockers as add-on treatment for schizophrenia
por: Lintunen, Jonne, et al.
Publicado: (2021)

Blood pressure lowering effects of β‐blockers as add‐on or combination therapy: A meta‐analysis of randomized controlled trials
por: Guo, Qian‐Hui, et al.
Publicado: (2023)

Effectiveness of antidepressants: an evidence myth constructed from a thousand randomized trials?
por: Ioannidis, John PA
Publicado: (2008)

Effects of add-on Celecoxib treatment on patients with schizophrenia spectrum disorders and inflammatory cytokine profile trial (TargetFlame): study design and methodology of a multicentre randomized, placebo-controlled trial
por: Strube, Wolfgang, et al.
Publicado: (2022)

Antidepressant use and psychosis hospitalization in persons with schizophrenia
por: Puranen, A., et al.
Publicado: (2023)

Impact of an educational module in antidepressant-naive patients prescribed antidepressants for depression: Pilot, proof-of-concept, randomized controlled trial
por: John, Annie P., et al.
Publicado: (2016)

Efficacy and Safety of Clidinium/Chlordiazepoxide as an Add-on Therapy in Functional Dyspepsia: A Randomized, Controlled, Trial
por: Puasripun, Siripa, et al.
Publicado: (2020)

Add-on effect of kinesiotape in patients with acute lateral ankle sprain: a randomized controlled trial
por: Shin, Jeong-Cheol, et al.
Publicado: (2020)

No add‐on effect of tDCS on fatigue and depression in chronic stroke patients: A randomized sham‐controlled trial combining tDCS with computerized cognitive training
por: Ulrichsen, Kristine M., et al.
Publicado: (2022)

Examining transcranial random noise stimulation as an add-on treatment for persistent symptoms in schizophrenia (STIM’Zo): a study protocol for a multicentre, double-blind, randomized sham-controlled clinical trial
por: Brunelin, Jerome, et al.
Publicado: (2021)

Development of self-image and its components during a one-year follow-up in non-referred adolescents with excess and normal weight
por: Mäkinen, Mauno, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_pdadossktat6n9kqcchn8kkqas